[HTML][HTML] Ferroptosis and its role in cardiomyopathy

D Li, W Pi, Z Sun, X Liu, J Jiang - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Heart disease is the leading cause of death worldwide. Cardiomyopathy is a disease
characterized by the heart muscle damage, resulting heart in a structurally and functionally …

New insights into the role of ferroptosis in cardiovascular diseases

AM Fratta Pasini, C Stranieri, F Busti, EG Di Leo… - Cells, 2023 - mdpi.com
Cardiovascular diseases (CVDs) are the principal cause of disease burden and death
worldwide. Ferroptosis is a new form of regulated cell death mainly characterized by altered …

Targeting PCSK9 ameliorates graft vascular disease in mice by inhibiting NLRP3 inflammasome activation in vascular smooth muscle cells

Y Zou, Z Chen, X Zhang, J Yu, H Xu, J Cui, Y Li… - Frontiers in …, 2022 - frontiersin.org
Background Graft vascular disease (GVD), which limits the long-term survival of patients
after solid-organ transplantation, is associated with both immune responses and …

Ferroptosis mechanisms and regulations in cardiovascular diseases in the past, present, and future

W Fang, S Xie, W Deng - Cell Biology and Toxicology, 2024 - Springer
Cardiovascular diseases (CVDs) are the main diseases that endanger human health, and
their risk factors contribute to high morbidity and a high rate of hospitalization. Cell death is …

An emerging double-edged sword role of ferroptosis in cardiovascular disease

S Qin, C Zhu, C Chen, Z Sheng… - … Journal of Molecular …, 2024 - spandidos-publications.com
The pathophysiology of cardiovascular disease (CVD) is complex and presents a serious
threat to human health. Cardiomyocyte loss serves a pivotal role in both the onset and …

Influence of donor age and donor-recipient age difference on intimal hyperplasia in pediatric patients with young and adult donors vs. adult patients after heart …

S Ulrich, L Arnold, S Michel, A Tengler… - Clinical Research in …, 2024 - Springer
Aim Optimal selection and allocation of donor hearts is a relevant aspect in transplantation
medicine. Donor age and cardiac allograft vasculopathy (CAV) affect post-transplant …

Transplant Vasculopathy Versus Native Atherosclerosis: Similarities and Differences

M Weis, M Weis - Transplantation, 2024 - journals.lww.com
Cardiac allograft vasculopathy (CAV) is one of the leading causes of graft failure and death
after heart transplantation. Alloimmune-dependent and-independent factors trigger the …

Early Use of Aspirin for Coronary Allograft Prophylaxis in Heart Transplant Recipients

CK Iglesias, JE Bloom, X Xiao, J Moskovitch… - …, 2024 - journals.lww.com
Background. Coronary allograft vasculopathy (CAV) remains a significant cause of morbidity
and mortality after heart transplantation. The use of aspirin for CAV prophylaxis has recently …

[HTML][HTML] The Korean Organ Transplant Registry (KOTRY): Third Official Adult Heart Transplant Report

HI Choi, SE Lee, J Hyun, D Kim, DJ Choi… - Korean Circulation …, 2024 - e-kcj.org
Methods Data from HTs performed at seven major centers in Korea between March 2014
and December 2020 were analyzed, focusing on immunosuppression, acute rejection …

[PDF][PDF] The Korean Organ Transplant Registry (KOTRY): Third Official Adult Heart Transplant Report

SE Lee - Korean Circ J, 2025 - e-kcj.org
The Korean Organ Transplant Registry (KOTRY): Third Official Adult Heart Transplant Report
Page 1 1/18 https://e-kcj.org AUTHOR'S SUMMARY This study examines 709 heart transplants …